Tech.euEurope
Biolevate lands €30M Series A to scale life sciences AI

Life sciences AI company Biolevate has raised €30 million in Series A funding to expand its platform for automating scientific and regulatory workflows and support its international growth.
Read at Tech.eu ↗Related

EuropePrimo raises $8M to bring autonomous AI agents to IT operations Tech.eu

EuropeMorphotonics closes €40M+ Series B to tackle AI devices’ hidden manufacturing bottleneck Tech.eu

EuropeZeliq raises €7M to build an agentic revenue workspace Tech.eu

EuropeLightspring raises €3.5M to tackle photonic chip manufacturing bottleneck Tech.eu

EuropeSpott secures $21M Series A to expand its AI platform for recruitment agencies Tech.eu
